Despite filing a fourth-quarter and yearend 2024 earnings report that the CEO described as "fantastic" yesterday afternoon, ...
Q4 2024 Earnings Call Transcript February 24, 2025 Tempus AI, Inc. misses on earnings expectations. Reported EPS is $-0.18 EPS, expectations were $-0.15. Operator: Thank you for standing by. My name ...
In a regulatory filing on Friday, Tempus AI (TEM) disclosed that Chairman and CEO Eric Lefkofsky sold a series of shares beginning on January 22, totaling about $62M. On January 22, Lefkofsky sold ...
Tempus AI Inc (TEM) reports impressive revenue growth, strategic acquisitions, and extended partnerships, setting the stage for a promising 2025.
Tempus, a leading healthcare technology company, has announced its strongest quarterly performance to date. According to Eric ...
Eric Lefkofsky, CEO and Chairman of Tempus AI , Inc. (NASDAQ:TEM), sold a significant portion of his holdings in the company according to a recent SEC filing. On February 19 and 20, Lefkofsky ...
ERIC P LEFKOFSKY, the CEO and Chairman of $TEM, sold 18,509 shares of the company on 02-19-2025 for an estimated $1,526,437. We received data on the trade from a ...
The company’s quarterly earnings will be released the same day. The call will feature Tempus Founder and CEO, Eric Lefkofsky, and Chief Financial Officer, Jim Rogers. The live audio webcast will be ...
Reports Q4 revenue $200.7M, consensus $202.8M. “Our performance in 2024 reflects the strength of our core businesses, as Genomics continued to ...
neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results